South San Francisco, CA, United States of America

Chong Han

USPTO Granted Patents = 14 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 34(Granted Patents)

Location History:

South San Francisco, CA (US) (2015 - 2020)
Foster City, CA (US) (2018 - 2024)

Company Filing History:

F. Hoffmann-la Roche Ag

patents

4. 1 out of 4,942

Hoffmann-la Roche Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410189 - Polymorphs and solid forms of (S)-2-2((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9- yl)amino)propanamide, and methods of production (2025-09-09),

2. 12071422 - Process for synthesis of quinazoline compounds (2024-08-27),

3. 11591345 - Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of production (2023-02-28),

4. 11028100 - Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of production (2021-06-08),

5. 10870626 - Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds (2020-12-22),

6. 10781219 - Process for the preparation of (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[F]imidazo[1,2-D][1,4]oxazepin-9-yl)amino) propanamide (2020-09-22),

7. 10457648 - Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds (2019-10-29),

8. 10329288 - Process for preparing a compound (2019-06-25),

9. 9975856 - Process for the preparation of (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid (2018-05-22),

10. 9969735 - Process for making tricyclic lactam compounds (2018-05-15),

11. 9790190 - Process for making hydroxylated cyclopentylpyrimidine compounds (2017-10-17),

12. 9676730 - Process for making hydroxylated cyclopentylpyrimidine compounds (2017-06-13),

13. 9416110 - Process for making hydroxylated cyclopentylpyrimidine compounds (2016-08-16),

14. 9221813 - Intermediates and processes for preparing compounds (2015-12-29),

Title: The Innovative Contributions of Chong Han

Introduction

Chong Han is a prominent inventor based in South San Francisco, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 14 patents to his name, his work has had a substantial impact on medical research and drug development.

Latest Patents

Chong Han's latest patents include innovative formulations such as polymorphs and solid forms of (S)-2-2((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide. He has also developed methods for producing crystalline polymorph forms of (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide (GDC-0077). Additionally, he has provided processes for synthesizing quinazoline compounds that are useful in cancer treatment.

Career Highlights

Chong Han has worked with notable companies in the pharmaceutical industry, including Genentech, Inc. and Array Biopharma Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Chong has collaborated with esteemed colleagues such as Francis Gosselin and Scott J Savage. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in pharmaceutical research.

Conclusion

Chong Han's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to improving cancer treatment. His innovative work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.